AFTER HRS.- JEFFERIES STARTS COVERAGE OF ACAD WITH BUY AND $13 TARGET. (LINK)
After-Hours Buzz: EA, BAC, DFS & More
Published: Monday, 18 Mar 2013 | 4:40 PM ET
By: JeeYeon Park
Jefferies started coverage of Acadia Pharmaceuticals with a "buy" recommendation and a price target of $13, sending shares higher in extended-hours trading.